Status:
COMPLETED
French Version of Fear-Avoidance Component Scale (FACS-FR)
Lead Sponsor:
Université de Sherbrooke
Conditions:
Kinesiophobia
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic musculoskeletal disorders are global burden for economy. Fear-avoidance (FA) seems be a predictor for the transition from subacute to chronic pain. One of the most famous scales to access FA i...
Detailed Description
The process is done in two steps to allow the achievement of our two study objectives (translation and validation), with two different cohorts of patients. First, for the French translation of the FA...
Eligibility Criteria
Inclusion
- At least 18 years old
- Current chronic pain complaint is not surgically treated (at least 6 weeks of pain)
- Not being currently treated by a physiotherapist for pain complaint
- French language is mother tongue
Exclusion
- Pain from a non-musculoskeletal origin (e.g., tumour)
- Neurological disease
- Impaired cognition
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05217017
Start Date
February 1 2022
End Date
February 1 2023
Last Update
March 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche du CHUS (CRCHUS)
Sherbrooke, Quebec, Canada, J1H 5N4